Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Small Molecules
Filter
Filter
Sort By
Newest First
Sector
Service / Activity
Reset
1 / 10
1 / 10
CDMO
Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites
Mikart
PR-10-24-NI-54
Oct 22, 2024
M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01
Sep 04, 2024
Developability
Assessing Developability and Designing Advanceable Formulations from the Start
Nazar Elkarim, Ph.D.
Mikart
PAO-09-24-CL-02
Aug 26, 2024
Liquid Suspensions
Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Gus LaBella
Mikart
PAO-07-24-CL-04
Jul 09, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-02
Mar 27, 2024
Nice Insight API Report
Small Molecule API Discovery and Development Trends
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-01
Mar 21, 2024
Biomanufacturing
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
Antheia
PR-M03-24-02
Mar 13, 2024
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
Olon
PR-M02-24-01
Feb 05, 2024
Chromatography
Navigating HPLC Method Development: Tips for Success
Ransom Jones
Mikart
PAO-12-23-CL-09
Jan 17, 2024
Process Chemistry
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
Jean-Francois Vincent-Rocan, Ph.D.
BIOVECTRA
PAO-12-23-CL-02
Dec 13, 2023
Is this Pharma’s Best Kept Secret? Partnering with Australian Companies for Pharmaceutical Development and Manufacturing
Grant Swart
Mayne Pharma Services
PAO-10-23-CL-04
Oct 18, 2023
Modified-Release Drug Formulations
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
Donald Loveday, Ph.D.; Bill McCarthy; Doug Hovey
SPI Pharma
PAO-05-23-CL-06
Jun 06, 2023
Biocatalysis
Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme
Olon
PR-M05-23-02
May 10, 2023
API
Enhanced Solubility through API Processing: Salt and Cocrystal Formation
Thomas Briel, Ph.D.; David Luedeker, Ph.D.
MilliporeSigma
PAO-05-23-CL-04
May 05, 2023
HPAPIs
An Introduction to HPAPIs and Cytotoxic Drugs
Roots Analysis
PAO-04-23-CL-04
Apr 25, 2023
New R&D Center
Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy
Peng Dai, Ph.D.; Steven Hu, Ph.D.
Asymchem
PAO-02-23-CL-07
Mar 09, 2023
Academic Research
Olon and The Chemistry Department of Politecnico University Launch a Research Project on Polymorphism and Characterization of API Solid State
Olon
PR-M02-23-02
Feb 21, 2023
Parenteral Drug Products
Innovating to Optimize Quality in Injectable Drugs
Michael Howell
Grifols
PAO-11-022-CL-16
Jan 12, 2023
Sustainable Manufacturing
Sustainability in Pharmaceutical Manufacturing: A CDMO’s Contribution
Mark McLaws, Ph.D.
Asymchem
PAO-11-022-CL-07
Nov 22, 2022
Olon, International API Supplier, Releases New 2022 Sustainability Report
Olon
PR-M11-22-08
Nov 22, 2022
